Tiburio Therapeutics grabs $31 mln Series A
Cambridge, Massachusetts-based Tiburio Therapeutics, a biopharmaceutical company newly launched by Cydan, has raised $31 million in Series A funding. The investors were New Enterprise Associates, Longitude Capital, Lundbeckfonden Ventures and Alexandria Venture Investments.
3 January 2019•1 min read
